Clinical Trial Applications - Stopped: Filter, Search, and view applications


Clear
Extended search...

Page 5 of 7, showing 10 Applications out of 68 total, starting on record 41, ending on 50

# Protocol No Study Title Investigator(s) & Site(s) Date Stopped

41.

ECCT/21/06/09   STEADFAST STUDY
    A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients ≥ 16 years with chronic kidney disease due to sickle cell nephropathy (STEADFAST)   
Principal Investigator(s)
1. Professor Benhards Ragama Ogutu Ogutu
2. Professor Frederick Asirwa Chite Chite
3. Dr Doreen Mutua Mutua
Site(s) in Kenya
1. Site 1300 - CREATES Strathmore University (Nairobi City county)
2. Site 1301 - International Cancer Institute (Uasin Gishu county)
3. Site 1302 - Gertrudes\'s Childrens Hospital (Nairobi City county)
 
Not recorded View

42.

ECCT/21/06/01   ACTIV-2/A5401
    ACTIV-2/A5401 "Adaptive Platform Treatment Trial for Outpatients with COVID-19" (Adapt Out COVID)_   
Principal Investigator(s)
1. Charles Meja Kwobah
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
Not recorded View

43.

ECCT/21/05/05   The “EMPATHY” Trial
    A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19.       
Principal Investigator(s)
1. DR LUCAS OTIENO TINA
2. Dr. Bernhards Ragama Ogutu
3. Dr Deborah Chepngeno Langat
4. Dr Videlis Nduba Nduba
5. Dr Janet Oyieko
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Kenyatta University Teaching Referral and Research Hospital (KUTRRH) (Nairobi City county)
3. Kenya Medical Research Institute/US Army Medical Research Directorate-Kenya-Kericho (Kericho county)
4. KEMRI, Centre for Respiratory Diseases Research (CRDR) (Nairobi City county)
5. KEMRI-USAMRD-A, Kisumu Field Station (Kisumu county)
 
Not recorded View

44.

ECCT/21/03/04   Adapt Out COVID
    ACTIV-2/A5401 Adaptive Platform Treatment Trial for Outpatients with COVID-19      
Principal Investigator(s)
1. Deborah Langat
Site(s) in Kenya
1. Moi University Clinical Research Center (Uasin Gishu county)
2. Kenya Impact Research and Development Organization Clinical Research Site (Kisumu county)
3. Kenya Medical Resrach Institute (Kericho county)
 
Not recorded View

45.

ECCT/21/03/02   PB-SAM
    Pancreatic Enzymes and Bile Acids: A Non-Antibiotic approach to Treat Intestinal Dysbiosis in Acutely Ill Severely Malnourished Children.   
Principal Investigator(s)
1. Robert Bandsma
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
4. Migori County Hospital (Migori county)
 
Not recorded View

46.

ECCT/20/12/03   CALINA STUDY
    A multicenter, open-label, single-arm study to evaluate the PK, safety, tolerability and efficacy of a new artemether-lumefantrine (2.5 mg:30 mg) dispersible tablet in the treatment of infants and neonates <5 kg body weight with acute uncomplicated Plasmodium falciparum malaria.   Study number: CCOA566B2307   
Principal Investigator(s)
1. Benhards Ragama Ogutu
Site(s) in Kenya
KEMRI-Centre for Clinical Research (CCR)
 
Not recorded View

47.

ECCT/20/11/05   HOPE Kids 2
    A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Voxelotor (GBT440) in Pediatric Participants with Sickle Cell Disease (HOPE Kids 2)   
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. KEMRI/CRDR Clinical Research Annex (Nairobi City county)
3. Strathmore University Medical Centre (Nairobi City county)
4. KEMRI/CRDR Siaya (Siaya county)
 
Not recorded View

48.

ECCT/20/11/03   IMR-SCD-301
    A Phase 2b Study to Evaluate the Safety and Efficacy of IMR-687 in Subjects with Sickle Cell Disease       
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
Site(s) in Kenya
1. Kenya Medical Research Institute-Kondele Children\'s Hospital (Kisumu county)
2. The Center For Respiratory Disease Research/KEMRI (Nairobi City county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
 
Not recorded View

49.

ECCT/19/12/02   VPM1002 Phase III PoI
    A multicenter, Phase III double blind, randomized active controlled study to evaluate efficacy and safety of VPM1002 in comparison with BCG in prevention of Mycobacterium tuberculosis infection in newborn infants.     
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI-CRDR Nairobi (Nairobi City county)
2. KEMRI-CRDR Siaya (Siaya county)
 
Not recorded View

50.

ECCT/19/08/01   Use of malaria infection by injection to study malaria transmission
    Safety and feasibility of a malaria transmission model in semi-immune Kenyan adults using Plasmodium falciparum sporozoites   
Principal Investigator(s)
1. Melissa Kapulu
2. Philip Bejon
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
Not recorded View